Efficacy and safety of faricimab for neovascular age-related macular degeneration: a systematic review and network meta-analysis

Efficacy and safety of faricimab for neovascular age-related macular degeneration: a systematic review and network meta-analysis

Objective To evaluate the efficacy and safety of faricimab compared with other anti-vascular endothelial growth factor (anti-VEGF) agents in treating neovascular age-related macular degeneration (nAMD) patients.Methods and analysis A systematic review (SR) was conducted up to January 2023. Network m...

Full description

Saved in:
Bibliographic Details
Main Authors: Francisco Rodríguez, Daniel Samacá-Samacá, Claudia Hernández-Castillo, Laura Prieto-Pinto, Carolina Sardi, Hugo Ocampo, Joshua Kock, Fabián Hernández
Format: Article
Language:English
Published: BMJ Publishing Group 2024-05-01
Series:BMJ Open Ophthalmology
Online Access:https://bmjophth.bmj.com/content/9/1/e001702.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items